Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$37.81 - $52.4 $852,804 - $1.18 Million
-22,555 Reduced 10.75%
187,249 $9.8 Million
Q1 2024

May 01, 2024

BUY
$33.68 - $41.95 $2.86 Million - $3.56 Million
84,825 Added 67.87%
209,804 $8.53 Million
Q4 2023

Feb 12, 2024

SELL
$33.32 - $42.1 $1.56 Million - $1.97 Million
-46,829 Reduced 27.26%
124,979 $4.62 Million
Q3 2023

Oct 23, 2023

SELL
$36.46 - $44.03 $4.82 Million - $5.82 Million
-132,201 Reduced 43.49%
171,808 $6.56 Million
Q2 2023

Jul 27, 2023

SELL
$30.28 - $38.74 $527,053 - $674,308
-17,406 Reduced 5.42%
304,009 $11 Million
Q1 2023

Apr 27, 2023

SELL
$32.86 - $55.7 $4.05 Million - $6.87 Million
-123,313 Reduced 27.73%
321,415 $12.3 Million
Q4 2022

Jan 18, 2023

SELL
$40.06 - $59.44 $434,851 - $645,221
-10,855 Reduced 2.38%
444,728 $0
Q3 2022

Dec 22, 2022

SELL
$38.53 - $51.78 $3.24 Million - $4.35 Million
-84,085 Reduced 15.58%
455,583 $18 Million
Q3 2022

Oct 18, 2022

BUY
$38.53 - $51.78 $6.43 Million - $8.64 Million
166,850 Added 44.75%
539,668 $21.3 Million
Q2 2022

Jul 25, 2022

BUY
$37.35 - $48.3 $4.36 Million - $5.63 Million
116,633 Added 45.53%
372,818 $16.4 Million
Q1 2022

Apr 20, 2022

BUY
$31.97 - $41.06 $8.19 Million - $10.5 Million
256,185 New
256,185 $10.2 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Bernzott Capital Advisors Portfolio

Follow Bernzott Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bernzott Capital Advisors with notifications on news.